Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Barsoumian HB"'
Autor:
Puebla-Osorio N; Department of Radiation Oncology-Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Fowlkes NW; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Barsoumian HB; Department of Radiation Oncology-Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Xega K; Takeda Development Centers Americas, Inc, Lexington, MA, United States., Srivastava G; ARTIDIS AG, Basel, Switzerland., Kettlun-Leyton C; Department of Radiation Oncology-Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Nizzero S; ARTIDIS AG, Basel, Switzerland., Voss T; Department of Radiation Oncology-Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Riad TS; Department of Radiation Oncology-Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Wong C; Takeda Development Centers Americas, Inc, Lexington, MA, United States., Huang A; Department of Radiation Oncology-Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Hu Y; Department of Radiation Oncology-Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Mitchell J; Department of Radiation Oncology-Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Kim M; Medical College of Wisconsin, Milwaukee, WI, United States., Rafiq Z; Department of Radiation Oncology-Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., He K; Department of Radiation Oncology-Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Sezen D; Department of Radiation Oncology-Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Hsu E; Department of Radiation Oncology-Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Masrorpour F; Department of Radiation Oncology-Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Maleki A; Department of Radiation Oncology-Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Leuschner C; Department of Radiation Oncology-Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Cortez MA; Department of Radiation Oncology-Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Oertle P; ARTIDIS AG, Basel, Switzerland., Loparic M; ARTIDIS AG, Basel, Switzerland., Plodinec M; ARTIDIS AG, Basel, Switzerland., Markman JL; Takeda Development Centers Americas, Inc, Lexington, MA, United States., Welsh JW; Department of Radiation Oncology-Research, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Publikováno v:
Frontiers in oncology [Front Oncol] 2024 Oct 09; Vol. 14, pp. 1407143. Date of Electronic Publication: 2024 Oct 09 (Print Publication: 2024).
Autor:
Hu Y; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA., Paris S; Department of Translational Science, Nanobiotix, Paris, France., Sahoo N; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang Q; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wang Q; Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Physics and Astronomy, Rice University, Houston, TX, USA., Barsoumian HB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA., Huang A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA., Da Silva J; Department of Translational Science, Nanobiotix, Paris, France., Bienassis C; Department of Translational Science, Nanobiotix, Paris, France., Leyton CSK; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA., Voss TA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA., Masrorpour F; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA., Riad T; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA., Leuschner C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA., Puebla-Osorio N; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA., Gandhi S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA., Nguyen QN; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA., Wang J; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Cortez MA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA., Welsh JW; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA. Jwelsh@mdanderson.org.
Publikováno v:
Journal of nanobiotechnology [J Nanobiotechnology] 2024 Oct 01; Vol. 22 (1), pp. 597. Date of Electronic Publication: 2024 Oct 01.
Autor:
He K; Department of Radiation Oncology, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital and Institute, Jinan, Shandong, China. hekewen9144@foxmail.com.; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. hekewen9144@foxmail.com., Puebla-Osorio N; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Barsoumian HB; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Sezen D; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Department of Radiation Oncology, Koç University School of Medicine, Istanbul, Turkey., Rafq Z; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Riad TS; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hu Y; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Huang A; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Voss TA; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Kettlun Leyton CS; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Schuda LJ; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Hsu E; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Heiber J; Mural Oncology PLC, Waltham, MA, USA., Cortez MA; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Welsh JW; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. jwelsh@mdanderson.org.
Publikováno v:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Sep 10; Vol. 43 (1), pp. 256. Date of Electronic Publication: 2024 Sep 10.
Autor:
He K; Department of Radiation Oncology, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital and Institute, Jinan, Shandong, China. hekewen9144@foxmail.com.; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. hekewen9144@foxmail.com., Puebla-Osorio N; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Barsoumian HB; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Sezen D; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Department of Radiation Oncology, Koç University School of Medicine, Istanbul, Turkey., Rafiq Z; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Riad TS; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Hu Y; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Huang A; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Voss TA; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Leyton CSK; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Schuda LJ; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Hsu E; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Heiber J; Mural Oncology PLC, Waltham, MA, United States., Cortez MA; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Welsh JW; Department of Radiation Oncology, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States. jwelsh@mdanderson.org.
Publikováno v:
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2024 Sep 02; Vol. 43 (1), pp. 251. Date of Electronic Publication: 2024 Sep 02.
Autor:
Verma V; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX., Barsoumian HB; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX., Welsh JW; Department of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX.. Electronic address: jwelsh@mdanderson.org.
Publikováno v:
Seminars in radiation oncology [Semin Radiat Oncol] 2024 Jul; Vol. 34 (3), pp. 272-275.
Autor:
Duong LK; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Corbali HI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Department of Medical Pharmacology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Türkiye., Riad TS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Ganjoo S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Nanez S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Voss T; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Barsoumian HB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Welsh J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Cortez MA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Publikováno v:
Frontiers in oncology [Front Oncol] 2024 Jan 08; Vol. 13, pp. 1358498. Date of Electronic Publication: 2024 Jan 08 (Print Publication: 2023).
Autor:
Barsoumian HB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA., He K; Department of Radiation Oncology, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital and Institute, Jinan, Shandong, China., Hsu E; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA., Bertolet G; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA., Sezen D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA.; Department of Radiation Oncology, Koç University School of Medicine, Istanbul, Turkey., Hu Y; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA., Riad TS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA., Cortez MA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA., Welsh JW; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, 6565 MD Anderson Blvd, Houston, TX, 77030, USA. jwelsh@mdanderson.org.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2023 Sep; Vol. 72 (9), pp. 3003-3012. Date of Electronic Publication: 2023 Jun 08.
Autor:
Hu Y; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Paris S; Department of Translational Science, Nanobiotix, Paris, France., Sahoo N; Department of Radiation Physics, and., Bertolet G; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wang Q; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wang Q; Department of Radiation Physics, and.; Department of Physics and Astronomy, Rice University, Houston, Texas, USA., Barsoumian HB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Da Silva J; Department of Translational Science, Nanobiotix, Paris, France., Huang A; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Doss DJ; Department of Genetics, and., Pollock DP; Department of Genetics, and., Hsu E; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Selene N; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Leyton CSK; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Voss TA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Masrorpour F; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Ganjoo S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Leuschner C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Pietz JT; Department of Strategic Communication, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Puebla-Osorio N; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Gandhi S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Nguyen QN; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Wang J; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Cortez MA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA., Welsh JW; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
Publikováno v:
JCI insight [JCI Insight] 2023 Jun 22; Vol. 8 (12). Date of Electronic Publication: 2023 Jun 22.
Autor:
Ganjoo S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Gupta P; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Corbali HI; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.; Department of Medical Pharmacology, Cerrahpasa Medical Faculty, Istanbul University-Cerrahpasa, Istanbul, Türkiye., Nanez S; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Riad TS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Duong LK; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Barsoumian HB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Masrorpour F; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Jiang H; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Welsh JW; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States., Cortez MA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, United States.
Publikováno v:
Frontiers in immunology [Front Immunol] 2023 Apr 26; Vol. 14, pp. 1172931. Date of Electronic Publication: 2023 Apr 26 (Print Publication: 2023).
Autor:
He K; Department of Radiation Oncology, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital and Institute, Jinan, Shandong, China.; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Barsoumian HB; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Puebla-Osorio N; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hu Y; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Sezen D; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Radiation Oncology, Koç University School of Medicine, Istanbul, Turkey., Wasley MD; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Bertolet G; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Zhang J; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Leuschner C; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Yang L; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Kettlun Leyton CS; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Fowlkes NW; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas., Green MM; Department of Veterinary Medicine and Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas., Hettrick L; Ionis Pharmaceuticals, Carlsbad, California., Chen D; Department of Radiation Oncology, Shandong First Medical University and Shandong Academy of Medical Sciences, Shandong Cancer Hospital and Institute, Jinan, Shandong, China., Masrorpour F; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Gu M; Department of Immunology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Maazi H; Ionis Pharmaceuticals, Carlsbad, California., Revenko AS; Ionis Pharmaceuticals, Carlsbad, California., Cortez MA; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas., Welsh JW; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Publikováno v:
Cancer immunology research [Cancer Immunol Res] 2023 Apr 03; Vol. 11 (4), pp. 486-500.